When barriers ignore the "rule-of-five"

Advanced Drug Delivery Reviews
Stefanie D KrämerSara Belli

Abstract

Why are a few drugs with properties beyond the rule of 5 (bRo5) absorbed across the intestinal mucosa while most other bRo5 compounds are not? Are such exceptional bRo5 compounds exclusively taken up by carrier-mediated transport or are they able to permeate the lipid bilayer (passive lipoidal diffusion)? Our experimental data with liposomes indicate that tetracycline, which violates one rule of the Ro5, and rifampicin, violating three of the rules, significantly permeate a phospholipid bilayer with kinetics similar to labetalol and metoprolol, respectively. Published data from experimental work and molecular dynamics simulations suggest that the formation of intramolecular H-bonds and the possibility to adopt an elongated shape besides the presence of a significant fraction of net neutral species facilitate lipid bilayer permeation. As an alternative to lipid bilayer permeation, carrier proteins can be targeted to improve absorption, with the potential drawbacks of drug-drug interactions and non-linear pharmacokinetics.

References

Oct 1, 1984·British Journal of Clinical Pharmacology·G Sjölin-Forsberg, J Hermansson
Apr 30, 1996·Proceedings of the National Academy of Sciences of the United States of America·E G SchuetzJ D Schuetz
Aug 1, 1997·Biophysical Journal·D HusterK Gawrisch
Nov 15, 2000·Acta Crystallographica. Section C, Crystal Structure Communications·W Clegg, S J Teat
Aug 23, 2002·Clinical Pharmacokinetics·Patric StenbergPer Artursson
Jun 14, 2005·Biophysical Journal·Anita V ThomaeStefanie D Krämer
Sep 9, 2005·The AAPS Journal·Qingcheng Mao, Jashvant D Unadkat
Dec 3, 2005·Biochimica Et Biophysica Acta·D BemporadJ W Essex
Nov 26, 2009·Chemistry & Biodiversity·Stefanie D KrämerHeidi Wunderli-Allenspach
Dec 17, 2009·Trends in Pharmacological Sciences·Olena KisReina Bendayan
Feb 24, 2010·Journal of Medicinal Chemistry·Bernd KuhnMartin Stahl
Jul 31, 2010·Nature Reviews. Drug Discovery·Kiyohiko SuganoFrank Senner
Oct 5, 2011·Essays in Biochemistry·Frances J Sharom
Jan 25, 2012·Nature Chemistry·G Richard BickertonAndrew L Hopkins
Mar 8, 2012·Journal of Chemical Information and Modeling·Cristiano R W GuimarãesSpiros Liras
Jun 19, 2012·Expert Opinion on Drug Delivery·Arik DahanRafik Karaman
Oct 9, 2012·Advanced Drug Delivery Reviews·Margarida EstudanteLeslie Z Benet
Dec 21, 2012·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Ji-Eon KimDae-Duk Kim
Feb 12, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Vinayak HosagraharaJayashree Giridhar
Mar 20, 2013·Molecular Aspects of Medicine·David E SmithMatthias A Hediger
Apr 2, 2013·The AAPS Journal·Thomayant PrueksaritanontJerome Hochman
Apr 24, 2013·Journal of Inherited Metabolic Disease·N Joan Abbott
Jun 25, 2013·Current Pharmaceutical Design·Nisha Vijay, Marilyn E Morris
Sep 7, 2013·Current Opinion in Pharmacology·Matthias Brandsch
Sep 14, 2013·Current Opinion in Pharmacology·Shingen MisakaMartin F Fromm
Sep 21, 2013·Journal of Medicinal Chemistry·Fabrizio Giordanetto, Jan Kihlberg
Sep 26, 2013·Current Opinion in Pharmacology·Ikumi Tamai, Takeo Nakanishi
Nov 12, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Klaus EyerStefanie D Krämer
Feb 11, 2014·Biophysical Journal·Igor VorobyovToby W Allen
Feb 12, 2014·Annual Review of Physiology·Michele VisentinI David Goldman
Mar 5, 2014·Expert Opinion on Drug Metabolism & Toxicology·Manuela de Lima Toccafondo Vieira, Carlos Alberto Tagliati
May 27, 2014·Expert Opinion on Drug Discovery·Bo FengLarry Tremaine
Sep 23, 2014·The AAPS Journal·Qingcheng Mao, Jashvant D Unadkat
Sep 23, 2014·Chemistry & Biology·Bradley Croy DoakJan Kihlberg

❮ Previous
Next ❯

Citations

Mar 2, 2016·Advanced Drug Delivery Reviews·Christel A S BergströmChristopher J H Porter
Jun 12, 2016·Advanced Drug Delivery Reviews·Christel A S Bergström, Christopher J H Porter
Nov 23, 2016·Future Medicinal Chemistry·Mickaël MarloyeFrançois Dufrasne
May 5, 2017·The Journal of Physical Chemistry. B·Deniz Sezer, Tuğçe Oruç
Sep 7, 2017·Organic & Biomolecular Chemistry·Adrian WhittyMengqi Zhong
Sep 14, 2018·Current Medicinal Chemistry·Charlene Gadais, Steven Ballet
Nov 14, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tarapong SrisongkramJarkko Rautio
Mar 13, 2018·International Journal of Peptide Research and Therapeutics·Thomas VorherrMichael Schaefer
Feb 2, 2021·European Journal of Medicinal Chemistry·Phelelisiwe S DubeRichard M Beteck
Feb 23, 2021·Journal of Medicinal Chemistry·Priyadeep BhutaniRaj Kumar
Mar 26, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Benjamin Kingsley HarleyTheophilus Christian Fleischer
Apr 30, 2021·Molecular Pharmaceutics·Mohammad Sharifian Gh
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Samson Olaitan OselusiSamuel Ayodele Egieyeh
Sep 20, 2017·Journal of Medicinal Chemistry·David A DeGoeyMichael D Wendt
Oct 18, 2017·ACS Omega·Jaime SameloMaria João Moreno
Aug 14, 2020·Molecular Pharmaceutics·Alex Avdeef, Manfred Kansy
Jul 2, 2019·Journal of Chemical Information and Modeling·Andrei L Lomize, Irina D Pogozheva
Jan 7, 2022·Expert Opinion on Therapeutic Patents·Christine Shing Wei Law, Keng Yoon Yeong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

© 2022 Meta ULC. All rights reserved